Cargando…

Pleiotropic effects of rosuvastatin on microvascular function in type 2 diabetes

Rosuvastatin is known to reduce low-density lipoprotein (LDL)-cholesterol and improve endothelial function. In addition to lipid-lowering, statins may exert pleiotropic (nonlipid lowering) effects on microvascular function. We compared the neurophysiological and vascular responses of dietary control...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parson, Henri K, Bundy, Meredith A, Dublin, Charlotte B, Boyd, Amanda L, Paulson, James F, Vinik, Aaron I
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2010
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047994/ https://www.ncbi.nlm.nih.gov/pubmed/21437072

Ejemplares similares

Aerobic training increases skin perfusion by a nitric oxide mechanism in type 2 diabetes
por: Colberg, Sheri R, et al.
Publicado: (2010)

Cardiac Autonomic Imbalance in Newly Diagnosed and Established Diabetes Is Associated with Markers of Adipose Tissue Inflammation
por: Lieb, David C., et al.
Publicado: (2012)

Balance Training Reduces Falls Risk in Older Individuals With Type 2 Diabetes
por: Morrison, Steven, et al.
Publicado: (2010)

Cardiac Autonomic Neuropathy in Diabetes: A Predictor of Cardiometabolic Events
por: Vinik, Aaron I., et al.
Publicado: (2018)

Role of Peroxynitrite in the Development of Diabetic Peripheral Neuropathy
por: Edwards, Joshua F., et al.
Publicado: (2015)

Bariatric Surgery Restores Cardiac and Sudomotor Autonomic C-Fiber Dysfunction towards Normal in Obese Subjects with Type 2 Diabetes
por: Casellini, Carolina M., et al.
Publicado: (2016)

Topiramate improves neurovascular function, epidermal nerve fiber morphology, and metabolism in patients with type 2 diabetes mellitus
por: Boyd, Amanda L, et al.
Publicado: (2010)

Effect of rosuvastatin on fasting and postprandial endothelial biomarker levels and microvascular reactivity in patients with type 2 diabetes and dyslipidemia: a preliminary report
por: Kim, Kyoung Min, et al.
Publicado: (2017)

Pleiotropic effects of rosuvastatin on the glucose metabolism and the subcutaneous and visceral adipose tissue behavior in C57Bl/6 mice
por: Neto-Ferreira, Rodrigo, et al.
Publicado: (2013)

Retraction Note: Effect of rosuvastatin on fasting and postprandial endothelial biomarker levels and microvascular reactivity in patients with type 2 diabetes and dyslipidemia: a preliminary report
por: Kim, Kyoung Min, et al.
Publicado: (2019)

Very rapid effect of pitavastatin on microvascular function in comparison to rosuvastatin: reactive hyperemia peripheral arterial tonometric study
por: Kono, Yasushi, et al.
Publicado: (2013)

Comparison of the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy and Rosuvastatin Monotherapy on Lipoprotein in Patients With Type 2 Diabetes: Multicenter Randomized Controlled Study
por: Lee, Jiwoo, et al.
Publicado: (2020)

Grand Challenges in Diabetes
por: Vinik, Aaron
Publicado: (2012)

Loss of RAGE Defense: A Cause of Charcot Neuroarthropathy?
por: Witzke, Kara A., et al.
Publicado: (2011)

Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes
por: Torimoto, Keiichi, et al.
Publicado: (2013)

Achievement of Lipid Targets with the Combination of Rosuvastatin and Fenofibric Acid in Patients with Type 2 Diabetes Mellitus
por: Rosenson, Robert S., et al.
Publicado: (2010)

The Pleiotropic Effects of Simvastatin on Retinal Microvascular Endothelium Has Important Implications for Ischaemic Retinopathies
por: Medina, Reinhold J., et al.
Publicado: (2008)

Protective Effect of Sitagliptin and Rosuvastatin Combination on Vascular Endothelial Dysfunction in Type-2 Diabetes
por: Nade, Vandana S., et al.
Publicado: (2015)

Current Perspectives on rosuvastatin
por: Hu, Miao, et al.
Publicado: (2013)

Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus
por: Hwang, You-Cheol, et al.
Publicado: (2019)

Nerve Growth Factor and Diabetic Neuropathy
por: Pittenger, Gary, et al.
Publicado: (2003)

Guidelines in the management of diabetic nerve pain: clinical utility of pregabalin
por: Vinik, Aaron I, et al.
Publicado: (2013)

The Hypolipidemic and Pleiotropic Effects of Rosuvastatin Are Not Enhanced by Its Association with Zinc and Selenium Supplementation in Coronary Artery Disease Patients: A Double Blind Randomized Controlled Study
por: Sena-Evangelista, Karine Cavalcanti Maurício, et al.
Publicado: (2015)

Pleiotropic Effects of Sitagliptin in the Treatment of Type 2 Diabetes Mellitus Patients
por: Kubota, Akira, et al.
Publicado: (2012)

Preparation and optimization of microemulsion of rosuvastatin calcium
por: Patel, Zalak B., et al.
Publicado: (2012)

Comparison between Atorvastatin and Rosuvastatin in Renal Function Decline among Patients with Diabetes
por: Han, Eugene, et al.
Publicado: (2017)

Utilizing a quality of life tool to examine the presence of fatigue in subjects with diabetes mellitus
por: Nguyen, Catherine, et al.
Publicado: (2023)

Rosuvastatin and chronic hepatitis C
por: Yoshida, Eric M.
Publicado: (2011)

Rosuvastatin induced photolocalized purpura
por: Thabouti, Marwa, et al.
Publicado: (2022)

Comparison of the effect of rosuvastatin versus rosuvastatin/ezetimibe on markers of inflammation in patients with acute myocardial infarction
por: Ren, Yizhi, et al.
Publicado: (2017)

Effect of rosuvastatin on vascular endothelial functions and inflammatory factors of patients with type 2 diabetes mellitus and coronary heart disease
por: Ma, Gang, et al.
Publicado: (2019)

Comparison of the Efficacy of Rosuvastatin 5 mg and 10 mg in Patients of Type 2 Diabetes Mellitus With Dyslipidemia
por: Aleem, Mudassar, et al.
Publicado: (2022)

Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease
por: Vinik, Aaron I, et al.
Publicado: (2013)

Pleiotropic Effects of Atorvastatin and Fenofibrate in Metabolic Syndrome and Different Types of Pre-Diabetes
por: Krysiak, Robert, et al.
Publicado: (2010)

Coronary Microvascular Remodeling in Type 2 Diabetes: Synonymous With Early Aging?
por: McCallinhart, Patricia E., et al.
Publicado: (2018)

Circadian‐timed quick‐release bromocriptine lowers elevated resting heart rate in patients with type 2 diabetes mellitus
por: Chamarthi, Bindu, et al.
Publicado: (2019)

Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study
por: Berne, Christian, et al.
Publicado: (2005)

A comparative evaluation of safety and efficacy of rosuvastatin, simvastatin, and atorvastatin in patients of type 2 diabetes mellitus with dyslipidemia
por: Adsule, Samir Maruti, et al.
Publicado: (2009)

A Comparison of Screening Tools for the Early Detection of Peripheral Neuropathy in Adults with and without Type 2 Diabetes
por: Brown, Jennifer J., et al.
Publicado: (2017)

Epidemiology of Diabetic Foot Ulcers and Amputations in Romania: Results of a Cross-Sectional Quality of Life Questionnaire Based Survey
por: Bondor, Cosmina I., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ohmqt1ft4136t2fa3io045na3l